skin care · ghk-cu · cosmetics law

Copper peptide serum: what the evidence shows

A copper peptide serum is a skin-care product containing GHK-Cu, the tripeptide Gly-His-Lys bound to copper. As a cosmetic it needs no FDA approval before sale. The controlled human evidence on skin is thin: the one randomized trial of a GHK-Cu skin-care regimen, with 13 people, found no objective difference.

Open Peptide Calculator editorial teamUpdated 13 sources

What is in a copper peptide serum?

The "copper peptide" in these serums is GHK-Cu: the three-amino-acid peptide glycyl-histidyl-lysine with a copper(II) ion bound to it.[4][5]

  • Names. GHK-Cu, copper tripeptide-1 (the ingredient-label name) and prezatide copper all refer to the same complex.[4]
  • Size. GHK alone is 340.38 g/mol; with copper, PubChem lists 402.92 g/mol.[5][4] See the tripeptide page for how GHK is built.
  • Not the same as injectable GHK-Cu. GHK-Cu sold for injection is a drug question with its own FDA safety notes; see the GHK-Cu page.

Does copper peptide serum work? The human studies

Placebo-controlled human evidence for GHK-Cu on facial skin is limited, and the only indexed randomized trial of a GHK-Cu skin-care regimen found no objective benefit.[6]

Human studies of topical GHK-Cu
StudyDesignWhat was testedResult
Miller 2006[6]Randomized, blinded evaluators; 13 completedGHK-Cu skin-care products after laser resurfacingNo difference in redness, wrinkles or skin quality on objective measures; higher patient satisfaction only
Mulder 1994[7]Randomized, evaluator-blinded, vehicle-controlledGHK-Cu gel on diabetic foot ulcers (wound care, not cosmetic)Median closure 98.5% vs 60.8%; infection 7% vs 34%
Patel 2024[8]Open-label, no control, manufacturer-linkedScalp regimen: copper tripeptide plus several other ingredientsImproved dandruff scores over 15 days; effect cannot be attributed to GHK-Cu
  • A 2026 systematic review found 20 eligible studies, 18 of them preclinical and 2 randomized trials, and concluded that well-designed clinical trials are limited.[9]
  • A 2025 review of GHK as an anti-wrinkle ingredient noted "a surprising absence of clinical studies" using it.[10]

That does not mean copper peptide serums do nothing; it means the published controlled evidence does not show what marketing often claims.

Is copper peptide serum FDA-approved?

No, and as a cosmetic it does not need to be: "cosmetic products and ingredients, with the exception of color additives, do not require FDA approval before they go on the market."[1]

  • Registration is not approval. Under the Modernization of Cosmetics Regulation Act (MoCRA), most cosmetic facilities must register and products must be listed with the FDA, but the FDA issues no certificate verifying either.[3] "FDA registered" never means "FDA approved".
  • Claims decide what a product is. A product meant for "cleansing, beautifying, promoting attractiveness, or altering the appearance" is a cosmetic; one meant to treat disease or "affect the structure or any function of the body" is a drug.[1] The FDA says that includes the skin: claims about affecting the skin's structure or function make a product a drug.[2]
  • No "cosmeceutical" category. FDA: "the term 'cosmeceutical' has no meaning under the law."[1]

Reading a serum labelThe FDA gives "regenerate cells" and "restore hair growth" as examples of claims that can make a product a drug. A cosmetic can legally promise to improve how skin looks, not to change how it works.

Topical vs injectable GHK-Cu

The FDA treats the two routes differently: non-injectable GHK-Cu is under evaluation for compounding, while injectable GHK-Cu carries a safety warning.

GHK-Cu by route (November 2026)
On the skin (serum, cream)Injected
Regulated asCosmetic, if no drug claims are madeDrug
FDA compounding statusNon-injectable forms: 503A Category 1 (under evaluation)[12]Formerly Category 2; FDA cites possible immune reactions from aggregation and impurities[11]
Human evidenceA few small skin and wound studiesNo published human trial

Athletes should note WADA's FAQ: S2 peptides and growth factors in cosmetic products are prohibited regardless of route, although WADA has not said whether GHK-Cu itself falls under S2.[13]

Frequently asked questions

Does copper peptide serum work?

The controlled evidence is thin. The only indexed randomized trial of a GHK-Cu skin-care regimen (13 people) found no objective difference in redness, wrinkles or skin quality, only higher satisfaction.[6]

Is copper peptide serum FDA-approved?

No. Cosmetics do not need FDA approval before sale; most must be registered and listed under MoCRA, which is not an approval.[1][3]

What is copper tripeptide-1?

The ingredient-label name for GHK-Cu, the tripeptide glycyl-histidyl-lysine bound to copper.[4]

Is a copper peptide serum the same as GHK-Cu injections?

No. The serum is a cosmetic applied to skin; injectable GHK-Cu is a drug question, with no published human trials and an FDA safety warning. See the GHK-Cu page.

Sources

  1. Is it a cosmetic, a drug, or both? (Or is it soap?) · U.S. Food and Drug Administration, content current September 11, 2024
  2. Cosmetics labeling claims · U.S. Food and Drug Administration, content current November 21, 2022
  3. Registration and listing of cosmetic product facilities and products · U.S. Food and Drug Administration, content current September 9, 2026
  4. PubChem CID 71587328: prezatide copper (GHK-Cu) · PubChem, NCBI, accessed November 13, 2026
  5. PubChem CID 73587: glycyl-L-histidyl-L-lysine (GHK) · PubChem, NCBI, accessed November 13, 2026
  6. Miller TR et al. Topical copper peptide after CO2 laser resurfacing (Arch Facial Plast Surg 2006;8:252–9) · Archives of Facial Plastic Surgery, 2006
  7. Mulder GD et al. Topical GHK-Cu gel for diabetic neuropathic ulcers (Wound Repair Regen 1994;2:259–69) · Wound Repair and Regeneration, 1994
  8. Patel MN et al. Scalp regimen with a copper tripeptide serum: open-label study (Cureus 2024;16:e70108) · PubMed 39449909, 2024
  9. Mokhtar J et al. The regenerative potential of GHK-Cu in aesthetic medicine: systematic review (Aesthet Surg J 2026) · PubMed 42619529, 2026
  10. Mortazavi SM et al. Topically applied GHK as an anti-wrinkle peptide (Bioimpacts 2025) · PubMed 39963574, 2025
  11. Certain bulk drug substances for use in compounding that may present significant safety risks · U.S. Food and Drug Administration, content current April 22, 2026
  12. Bulk drug substances nominated for use in compounding under section 503A (category lists) · U.S. Food and Drug Administration, updated May 14, 2026
  13. The Prohibited List (2026, online version and FAQ) · World Anti-Doping Agency, accessed November 13, 2026